Regular Mammograms may reduce Breast Cancer Mortality by 49%

Regular mammograms may reduce breast cancer mortality by almost 50%Women who took Diethylstilbestrol DES and those who were exposed to the drug prenatally have an increased risk of breast cancer after age 40! Yet very few doctors know about DES as a risk factor and mammograms are not prescribed under the age of 50 in the UK unless breast cancer runs in your family …

Read Regular mammograms may reduce breast cancer mortality by almost 50%

Eli Lilly lawsuit – When the Melnick sisters reached a settlement with the drug company

The settlement, for an undisclosed sum, was reached ­on Day Two, after the first witness in the case, a Harvard public health doctor, testified that the drug DES, which was promoted by Lilly as a way to prevent miscarriages had indeed been shown to cause cancer. It also came ­after a lawyer for the sisters ­argued that Lilly had failed to test the drug’s effect on fetuses before promoting it.

Is a Settlement good enough?

…we believe the settlement is in the best interest of the company…   …settling this trial helps us get back to what we want to focus on as a company; developing important new medications through research and partnerships with doctors and patients…

Eli Lilly statement said. So, in other words: “we can’t care less, that will keep them quiet and in the meantime we’ll continue to poison people” …
As a DES Daughter DES Daughter Google+ icon , I feel disgusted but happy for the Melnick sisters!

Rethink Breast Cancer presents: Your Man Reminder

This app gives you regular reminders from hotties to check your breasts

That will put a smile on your face! Today, there are many risk factors that have contributed to more women being diagnosed with breast cancer (diethylstilbestrol is one of them) so let this hot guy show you how to give your breasts some TLC. and enjoy this great video 😉

BPA : French researchers say they have uncovered new Risks

Like DES, BPA is a synthetic oestrogen with similar to identical effects on the human bodyOur study is the first to show that BPA can alter thyroid function of pregnant animals and their offspring in a long-gestation species with similar regulation of thyroid function as humans” said Catherine Viguié, PhD, of Toxalim, Research Centre in Food Toxicology in Toulouse, France and lead author of the study.

Read Study Links BPA to Lower Thyroid Function

See Health News PinBoard on Pinterest  Follow DES Daughter on Pinterest

Eli Lilly lawsuit – When the Melnick sisters’ trial began – The McCarthy family interview

Watch DES Activist and DES Daughter Caitlin McCarthy with her DES mother discuss the Melnick sisters‘ trial after the opening statements on January 09, 2013

Silent Trauma: Judith Barrow’s new fiction book based on Stilboestrol drug

Silent Trauma: Judith Barrow's new fiction book based on Stilboestrol drug

The next big thing is Judith Barrow’s new book called “Silent Trauma”, a fiction built on fact around the DES story – Four women fight back, leading the way for other women …

The Story of Silent Trauma is fiction – the facts are real

Read an extract

Buy from Amazon

More DES DiEthylStilbestrol Resources

US Lawyer to hunt for “DES Daughters in UK” … and beyond …

Washington-based lawyer Aaron Levine termedf the DES as “quackery”

Lawyer to hunt for Hopefully things will change in the UK, and DES Daughters, DES Sons and their children (for the few of us who were able to have children), will be taken seriously and offered adequate healthcare …

Read Lawyer to hunt for ‘DES daughters’ in UK., on 01/22/2012.

About Attorneys at Aaron M. Levine & Associates.

More DES DiEthylStilbestrol Resources

Susan’s Cancer Survival Story unlike any other

The journey to get here has been nothing short of amazing

Growing Bolder: A Cancer Survival Story unlike any otherThis is the story of an AMAZING woman! How a beautiful DES Daughter managed to overcome life threatening DES health issues with her positive attitude and passion for swimming …
Truly inspiring!

Read Growing Bolder: A Cancer Survival Story unlike any other

Related post: Beating Cancer One Lap at a Time

More DES DiEthylStilbestrol Resources

DES Exposure, Woman’s significant increased Risk of many Cancers and Infertility

Insidermedicine In 60 – October 6, 2011

Exposure to Diethylstilbestrol in the womb raises a woman’s risk of many cancers, according to a report published in the New England Journal of Medicine.

Researchers studied over 6500 women, 4600 of whom were exposed to DES in the womb. Results showed that this exposure significantly increased risk of many cancers and fertility problems, including a 40x increased risk of clear-cell adenocarcinoma, 8x increased risk of neonatal death, 2.4x increased risk of infertility and a 1.8x increased risk of breast cancer.

More DES DiEthylStilbestrol Resources

Mice Study shows DES GrandDaughters may have increased Rates of Cancer

Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol

Mice Study shows DES Granddaughters’ may have increased Rates of Cancer” … scientists at the National Institute of Environmental Health Sciences report that they have observed an increase in cancers, including cancer of the uterus, in female mice whose mothers were exposed to DES in utero — while in the uterus … ”

1998 Study Abstract


Prenatal exposure to diethylstilbestrol (DES) has been associated with the subsequent development of reproductive tract abnormalities, including poor reproductive outcome and neoplasia, in experimental animals and humans. Experimental animal studies with chemical carcinogens have raised the possibility that adverse effects of DES may be transmitted to succeeding generations. To evaluate this possibility and to determine if there is a sensitive window of developmental exposure, outbred CD-1 mice were treated with DES during three stages of development: group 1 was treated on days 9-16 of gestation (2.5, 5 or 10 microg/kg maternal body wt), the time of major organogenesis; group II was treated once on day 18 of gestation (1000 microg/kg maternal body wt) just prior to birth; group III was treated on days 1-5 of neonatal life (0.002 microg/pup/day). Female mice (F1) in each group were raised to sexual maturity and bred to control males. As previously reported, fertility of the F1 DES-exposed females was decreased in all groups. Female offspring (DES lineage or F2) from these matings were raised to maturity and housed with control males for 20 weeks. The fertility of these DES lineage female mice was not affected by DES exposure of their ‘grandmothers’. DES lineage mice were killed at 17-19 and 22-24 months of age. An increased incidence of malignant reproductive tract tumors, including uterine adenocarcinoma, was seen in DES lineage mice but not in corresponding controls; the range and prevalence of tumors increased with age. Because uterine adenocarcinomas were seen in all three DES groups, all developmental exposure periods were considered susceptible to the adverse effects of DES. These data suggest that the reduced fertility observed in the DES F1 female mice was not transmitted to their descendants; however, increased susceptibility to tumor formation is apparently transmitted to subsequent generations.
Read ‘DES Daughters’ Had Increased Rates Of Cancer; An Animal Study Shows ‘DES Granddaughters’ May Too, qajyjuvoma, Medical News, June 26, 2012.

More DES DiEthylStilbestrol Resources